Skip to content

Clinical research and application of accurate refractive interstitial analysis system

Clinical research and application of accurate refractive interstitial analysis system

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043179
Enrollment
Unknown
Registered
2021-02-08
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cataract

Interventions

Gold Standard:Slit lamp biological microscope
Index test:swept-source&#32
image

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The patient has signed an informed consent form. 2. Pupils move freely without adhesion; intraocular pressure (IOP) is between 10mmHg and 20mmHg, and can cooperate to complete the inspection and follow-up. 3. No serious heart, liver, kidney and blood system diseases.

Exclusion criteria

Exclusion criteria: 1. Exclude patients with opacity of the refractive interstitium caused by corneal disease, uveitis, vitreous-related diseases, and retinal detachment after silicone oil injection; 2. Those who have severely impaired cognitive function, have no self-consciousness, and cannot participate in follow-up or experimentation without family accompany; 3. Participated in other clinical trials in the past 3 months.

Design outcomes

Primary

MeasureTime frame
swept-source optical coherence tomography image;SEN, SPE, ACC, AUC of ROC;consistency;

Countries

China

Contacts

Public ContactFang Liu

Shanghai Tenth People's Hospital

fangl2000@hotmail.com+86 18917687449

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026